Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women.

@article{Hodis2003HormoneTA,
  title={Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women.},
  author={Howard N. Hodis and Wendy J. Mack and Stanley Paul Azen and Rog{\'e}rio Souza Lobo and Donna Shoupe and Peter R. Mahrer and David P. Faxon and Linda Cashin-Hemphill and Miguel E Sanmarco and William J. French and Thomas L. Shook and Thomas D Gaarder and Anilkumar O Mehra and Ramin Rabbani and Alex Sevanian and Asit Baran Shil and Mina Torres and K Heiner Vogelbach and Robert H. Selzer},
  journal={The New England journal of medicine},
  year={2003},
  volume={349 6},
  pages={535-45}
}
BACKGROUND In postmenopausal women with coronary artery disease, conjugated equine estrogen with or without continuous administration of medroxyprogesterone acetate has failed to slow the progression of atherosclerosis. Whether 17beta-estradiol (the endogenous estrogen molecule) alone or administered sequentially with medroxyprogesterone acetate can slow the progression of atherosclerosis is unknown. METHODS We conducted a double-blind, placebo-controlled trial in 226 postmenopausal women… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 101 extracted citations

Similar Papers

Loading similar papers…